Search for
Menu
About
+
Overview
Impact
Partners
Team
Entrepreneurs
+
Venture Studio
Our Mentors
Rev1 at The Peninsula
Rev1 Labs
Corporates
Capital
+
Rev1 Capital
Funds
Portfolio
Resources
+
Startup Resources
Blog
Entrepreneur Toolkit
Jobs
Events
Get Started
About
+
Overview
Impact
Partners
Team
Entrepreneurs
+
Venture Studio
Our Mentors
Rev1 at The Peninsula
Rev1 Labs
Corporates
Capital
+
Rev1 Capital
Funds
Portfolio
Resources
+
Startup Resources
Blog
Entrepreneur Toolkit
Jobs
Events
Get Started
Search for
Merlin Therapeutics Awarded Maximum Amount Under NIH STTR Grant to Develop Gene Therapy for Neurofibromatosis Type 2 (NF2)
By
Giselle Planchart
on
09/30/2024
Merlin Therapeutics Awarded Maximum Amount Under NIH STTR Grant to Develop Gene Therapy for Neurofibromatosis Type 2 (NF2)
Merlin Therapeutics Awarded Maximum Amount Under NIH STTR Grant to Develop Gene Therapy for Neurofibromatosis Type 2 (NF2)
